A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [11C]erlotinib and [18F]afatinib in lung cancer-bearing mice

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [11C]erlotinib and [18F]afatinib in lung cancer-bearing mice

Bibliographic Details
Main Authors: Slobbe, Paul, Windhorst, Albert D, Stigter-van Walsum, Marijke, Smit, Egbert F, Niessen, Heiko G, Solca, Flavio, Stehle, Gerd, van Dongen, Guus A M S, Poot, Alex J
Format: Online
Language:English
Published: Springer Berlin Heidelberg 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385286/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385286/

Similar Items